JPS497237A - - Google Patents

Info

Publication number
JPS497237A
JPS497237A JP48041750A JP4175073A JPS497237A JP S497237 A JPS497237 A JP S497237A JP 48041750 A JP48041750 A JP 48041750A JP 4175073 A JP4175073 A JP 4175073A JP S497237 A JPS497237 A JP S497237A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48041750A
Other languages
Japanese (ja)
Other versions
JPS5825656B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS497237(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of JPS497237A publication Critical patent/JPS497237A/ja
Publication of JPS5825656B2 publication Critical patent/JPS5825656B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP48041750A 1972-04-12 1973-04-12 Dopamine energy production Expired JPS5825656B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
JPS497237A true JPS497237A (en) 1974-01-22
JPS5825656B2 JPS5825656B2 (en) 1983-05-28

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
JP48041750A Expired JPS5825656B2 (en) 1972-04-12 1973-04-12 Dopamine energy production
JP57149025A Granted JPS58131945A (en) 1972-04-12 1982-08-27 Manufacture of dopamine derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP57149025A Granted JPS58131945A (en) 1972-04-12 1982-08-27 Manufacture of dopamine derivative

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH580563A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL94207B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
KR840000486A (en) * 1981-07-22 1984-02-22 원본미기재 Method for preparing substituted pyrrolidine
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (en) * 1993-04-13 1998-01-22 Duphar Int Res Manufacture of dobutamine compounds
SI1546088T1 (en) 2002-10-03 2015-04-30 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (en) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Compounds for improving or treating AIDS and other viral diseases and HIV-related infectious diseases and compositions thereof, compositions containing such compounds, methods for treating such diseases and infectious diseases, and methods for producing such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
ES2547730T3 (en) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Cognitive impairment inhibitors
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CN104053435A (en) * 2011-08-25 2014-09-17 考格尼申治疗股份有限公司 Compositions and methods for treating neurodegenerative disease
DK3498692T3 (en) 2014-01-31 2022-05-16 Cognition Therapeutics Inc Isoindoline compositions and methods for treating neurodegenerative disease and macular degeneration
BR112019023851A2 (en) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compounds, their pharmaceutical compositions and methods for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
NL174459B (en) 1984-01-16
GB1392674A (en) 1975-04-30
CH569691A5 (en) 1975-11-28
AU5438573A (en) 1974-10-17
CS190406B2 (en) 1979-05-31
IL42016A (en) 1976-05-31
DD107670B3 (en) 1988-04-06
YU37113B (en) 1984-08-31
HU166213B (en) 1975-02-28
IE37511B1 (en) 1977-08-03
RO70892A (en) 1982-02-26
IL42016A0 (en) 1973-06-29
ES413639A1 (en) 1976-01-16
YU97673A (en) 1982-02-25
KE2870A (en) 1978-09-01
BE798051A (en) 1973-10-11
KR790000113B1 (en) 1979-03-20
RO65105A (en) 1980-01-15
PH11041A (en) 1977-10-25
AT323719B (en) 1975-07-25
CH580563A5 (en) 1976-10-15
YU36483B (en) 1984-02-29
YU321279A (en) 1983-04-27
CA1018188A (en) 1977-09-27
JPS6221343B2 (en) 1987-05-12
JPS5825656B2 (en) 1983-05-28
SU496719A3 (en) 1975-12-25
FR2182947B1 (en) 1976-07-02
BG23001A3 (en) 1977-05-20
NL174459C (en) 1984-06-18
DE2317710C2 (en) 1983-08-04
ZA732136B (en) 1974-03-27
SE399064B (en) 1978-01-30
NL7305097A (en) 1973-10-16
JPS58131945A (en) 1983-08-06
AR203822A1 (en) 1975-10-31
PL94207B1 (en) 1977-07-30
DE2317710A1 (en) 1973-10-18
DD107670A5 (en) 1974-08-12
MY7800381A (en) 1978-12-31
DK142750B (en) 1981-01-12
HU167597B (en) 1975-11-28
FR2182947A1 (en) 1973-12-14
HK50178A (en) 1978-09-15
CS190448B2 (en) 1979-05-31
PL90695B1 (en) 1977-01-31
DK142750C (en) 1981-08-17
AU472734B2 (en) 1976-06-03
CY963A (en) 1978-12-22

Similar Documents

Publication Publication Date Title
FR2182947B1 (en)
FR2211612B1 (en)
FR2228327B1 (en)
FR2177681A1 (en)
JPS4938014U (en)
JPS4915338U (en)
JPS4898943U (en)
JPS4899245U (en)
JPS4897417U (en)
JPS4896083U (en)
JPS4891376U (en)
CH581681A5 (en)
BG20796A3 (en)
SE7310614L (en)
CH582677A5 (en)
BG17907A1 (en)
BG18199A1 (en)
BG18232A1 (en)
CH577604A5 (en)
CH581586A5 (en)
BG18939A1 (en)
BG19400A1 (en)
CH580921A5 (en)
CH580290A5 (en)
CH580193B5 (en)